doi: 10.2337/diacare.26.12.3352.
Prospective audit of the introduction of insulin glargine (lantus) into clinical practice in type 1 diabetic patients
- PMID: 14633830
- DOI: 10.2337/diacare.26.12.3352
Item in Clipboard
Prospective audit of the introduction of insulin glargine (lantus) into clinical practice in type 1 diabetic patients
Diabetes Care.
2003 Dec.
No abstract available
Similar articles
-
Studies show Lantus to be effective, safe and flexible in the treatment of type 1 diabetes.Diabetes Technol Ther. 2002;4(5):744-5. Diabetes Technol Ther. 2002. PMID: 12458569 No abstract available.
-
Similar A1C outcomes in type 1 diabetic patients undergoing intensive diabetes management with preprandial rapid-acting insulin and either CSII or glargine.Diabetes Care. 2004 Jan;27(1):272-3. doi: 10.2337/diacare.27.1.272-a. Diabetes Care. 2004. PMID: 14694001 Clinical Trial. No abstract available.
-
Will the use of insulin analogs improve glycemic control during adolescence?Pediatr Diabetes. 2003 Jun;4(2):61-3. doi: 10.1034/j.1399-5448.2003.00016.x. Pediatr Diabetes. 2003. PMID: 14655260 No abstract available.
-
[Long acting insulin analogs: possibly more stable glucose regulation].Ned Tijdschr Geneeskd. 2004 Aug 21;148(34):1674-8. Ned Tijdschr Geneeskd. 2004. PMID: 15453119 Review. Dutch.
-
Insulin glargine clinical trials.Clin Ther. 2004 Jul;26(7):1179-81; discussion 1182-3. doi: 10.1016/s0149-2918(04)90190-7. Clin Ther. 2004. PMID: 15336483 Review. No abstract available.
Cited by
-
From the coalface: does glargine insulin improve hypoglycaemic episodes, glycaemic control or affect body mass in type 1 diabetic subjects who are attending a 'routine' diabetes clinic?Diabetologia. 2006 Nov;49(11):2793-4. doi: 10.1007/s00125-006-0454-6. Epub 2006 Sep 19. Diabetologia. 2006. PMID: 17047914 No abstract available.
-
Quality of Life of Patients with Type 1 Diabetes Mellitus Using Insulin Analog Glargine Compared with NPH Insulin: A Systematic Review and Policy Implications.Patient. 2018 Aug;11(4):377-389. doi: 10.1007/s40271-017-0291-3. Patient. 2018. PMID: 29322308 Free PMC article.
-
Improved glycaemic control by switching from insulin NPH to insulin glargine: a retrospective observational study.Cardiovasc Diabetol. 2009 Jan 19;8:3. doi: 10.1186/1475-2840-8-3. Cardiovasc Diabetol. 2009. PMID: 19152692 Free PMC article.
-
Insulin glargine in the treatment of type 1 and type 2 diabetes.Vasc Health Risk Manag. 2006;2(1):59-67. doi: 10.2147/vhrm.2006.2.1.59. Vasc Health Risk Manag. 2006. PMID: 17319470 Free PMC article. Review.
-
Switching from premixed insulin to glargine-based insulin regimen improves glycaemic control in patients with type 1 or type 2 diabetes: a retrospective primary-care-based analysis.Cardiovasc Diabetol. 2009 Feb 16;8:9. doi: 10.1186/1475-2840-8-9. Cardiovasc Diabetol. 2009. PMID: 19220880 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
